¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2022-12-17

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2022-12-17
±³À°ÀÏÀÚ : 2022-12-17
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º ¿ÀÅ°µå·ë ¿Ü 1°³·ë  
±³À°ÁÖÁ¦ : 2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½É±Ù°æ»ö¿¬±¸È¸  
´ã´çÀÚ : ¹Ú¹Ì°æ
¿¬¶ôó : 062-220-4227  
À̸ÞÀÏ : myocardial-mr@daum.net      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 120¸í
Èñ¸ÁÆòÁ¡ : 4Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 8 ½Ã°£ 15ºÐ  
¼¼ºÎ¼ö°­·á : 0¿ø      
ºñ°í       

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 12-17 Orchid Room 08:30~08:40 Viability Test is not Viable!!, Just CABG It!!  ¼­Á¸(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 12-17 Orchid Room 08:40~08:50 Viability Test is Still Viable!!  Á¶ÇöÀç(¼­¿ïÀÇ´ë) 
±³À°½Ã°£ 12-17 Orchid Room 08:50~09:00 Optimal medical therapy is the Key; ARNI, SGLT2 Inhibitor, and so on  À±Á¾Âù(°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 12-17 Orchid Room 09:00~09:10 PCI should be REVIVED for Patients with ischemic cardiomyopathy  ÀÌÁÖ¸í(¼º±Õ°üÀÇ´ë) 
Åä·Ð 12-17  09:10~09:30 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Camellia Room 08:30~08:40 Case 1: My first night in cath lab on call  ÀüÈ£¼º(¿øÁÖ¼¼ºê¶õ½º) 
Åä·Ð 12-17  08:40~08:50 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Camellia Room 08:50~09:00 Case 2: AMI with unusual coronary artery dissection and large thrombus burden  À±Àç¿ë(±¸¹ÌÂ÷º´¿ø) 
Åä·Ð 12-17  09:00~09:10 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Camellia Room 09:10~09:20 Case 3: Treating AMI with Ambiguous Lesion: Which One is Culprit Lesion?  È²µµ¿¬(¼­¿ïÀÇ´ë) 
Åä·Ð 12-17  09:20~09:30 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 09:30~09:40 FRAME-AMI: FFR versus angiography-guided PCI in AMI with multivessel disease  ÇÑÁÖ¿ë(¼º±Õ°üÀÇ´ë) 
±³À°½Ã°£ 12-17 Camellia Room 09:30~09:40 Case 1: AMI Patients with severe LV dysfunction: Revascularization or medical therapy  ±âÀ¯Á¤(°æÈñÀÇ´ë) 
Åä·Ð 12-17  09:40~09:50 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 09:50~10:00 PACIFIC-AMI: Factor XIa inhibitor asundexian on top of DAPT after AMI  ¹Ú¿ëÈÖ(°æ»óÀÇ´ë) 
±³À°½Ã°£ 12-17 Camellia Room 09:50~10:00 Case 2: Elderly patients with cardiogenic shock requring mechanical circulatory support: ethics and evidence  Àå¿ìÁø(ÀÌÈ­¿©´ë) 
Åä·Ð 12-17  10:00~10:10 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 10:10~10:20 BOX: how to optimize oxygen therapy and blood pressure in post-resuscitation care  ¿øÈ£¿¬(Áß¾ÓÀÇ´ë) 
±³À°½Ã°£ 12-17 Camellia Room 10:10~10:20 Case 3: AMI Patients with high bleeding risk and complex lesion  ±è³²±Õ(°æºÏÀÇ´ë) 
Åä·Ð 12-17  10:20~10:30 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ12-17  10:30~11:00 È޽Ġ () 
±³À°½Ã°£ 12-17 Orchid Room 11:00~11:10 What to do if you question cardiac troponin values in acute and emergency setting?  À±¿µÁø(¿øÁÖ¼¼ºê¶õ½º) 
±³À°½Ã°£ 12-17 Camellia Room 11:00~11:10 Case 1: Never Treat the Non-Culprit in the Same Setting !!!  ÀÌÁöÇö(ÇѾçÀÇ´ë) 
Åä·Ð 12-17  11:10~11:20 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 11:20~11:30 Periprocedural MI: is there a right definition and clinical significance?  ¹ÚÁö¿µ(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 12-17 Camellia Room 11:20~11:30 Case 2: Fix it All As Many As You Can in the Same Setting !!!  Â÷Á¤ÁØ(°í·ÁÀÇ´ë) 
Åä·Ð 12-17  11:30~11:40 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 11:40~11:50 How to evaluate COVID-19 patients with myocardial injury  ¹®Àαâ(¼øõÇâÀÇ´ë) 
±³À°½Ã°£ 12-17 Camellia Room 11:40~11:50 Case 3: One Stage Multivessel PCI in Patients with cardiogenic shock under hemodynamic support  ÀÓ¿ëȯ(Àü³²ÀÇ´ë) 
Åä·Ð 12-17  11:50~12:00 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±âŸ 12-17 Orchid Room 12:00~12:10 WeKnew ¼Ò°³, ÄÁÅÙÃ÷ ½Ã¿¬ ¹× MOU ü°á½Ä  È²º¸À²(À§´º) 
±³À°½Ã°£ 12-17 Orchid Room 12:10~12:25 Earlier & Longer is Better!- Clinical Benefits of Evolocumab in ACS  À̽ÂÇå(Àü³²ÀÇ´ë) 
±³À°½Ã°£ 12-17 Orchid Room 12:25~12:40 Optimal comorbidity management for CV protection in hypertensive patients with dyslipidemia  È«¼øÁØ(°í·ÁÀÇ´ë) 
½Ä»ç 12-17  12:40~13:00 ½Ä»ç  () 
±³À°½Ã°£ 12-17 Orchid Room 13:00~13:10 Do the clinical study results support the use of EMCO and Impella rather than IABP in cardiogenic shock?  ±è¿õ(¿µ³²ÀÇ´ë) 
Åä·Ð 12-17  13:10~13:20 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 13:20~13:30 Do you prefer culprit-only PCI? If then, how can you detect culprit lesion in multivessel disease?  ±è¹Îö(Àü³²ÀÇ´ë) 
Åä·Ð 12-17  13:30~13:40 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 13:40~13:50 How to transition from ECMO to heart transplantation?  ±èÁ¤¼ö(ºÎ»êÀÇ´ë) 
Åä·Ð 12-17  13:50~14:00 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
±³À°½Ã°£ 12-17 Orchid Room 14:00~14:20 ½ÉÇ÷°ü°è ÇʼöÀÇ·áÁ¤Ã¥ ¹æ¾È  ±èÇѼ÷(Áúº´Á¤Ã¥°úÀå) 
±³À°½Ã°£ 12-17 Orchid Room 14:20~14:40 ½ÉÀå³»°ú Àǻ簡 »ý°¢ÇÏ´Â ÇʼöÀÇ·áÁ¤Ã¥ ¹æÇâ  °­ÇöÀç(¼­¿ïÀÇ´ë) 
Åä·Ð 12-17  14:40~15:00 Åä·Ð  ´Ù°­»ç(´Ù¼Ò¼Ó) 
È޽Ġ12-17  15:00~15:20 È޽Ġ () 
±³À°½Ã°£ 12-17 Orchid Room 15:20~15:35 Current trend of developing clinical practice guideline  ¹Úµ¿¾Æ(Çѱ¹º¸°ÇÀǷῬ±¸¿ø) 
±³À°½Ã°£ 12-17 Orchid Room 15:35~15:50 What we have done for Korean guideline of myocardial infarction  ±èÇö±¹(Á¶¼±ÀÇ´ë) 
±³À°½Ã°£ 12-17 Orchid Room 15:50~16:05 Gap between real practice and guideline in AMI: insight from survey for lipid management  ÀÌ»ó¿±(Áß¾ÓÀÇ´ë) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2022 ½É±Ù°æ»ö¿¬±¸È¸ µ¿°è ½ÉÆ÷Áö¾ö : 2022-12-17""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ¼­¿ï¼º¸ðº´¿ø ´ëÇÑ ÆÄŲ½¼º´ ¹× ÀÌ»ó¿îµ¿Áúȯ ÇÐȸ(KMDS) 2022 µ¿°èº¸¼ö±³À° : 2022-12-17
´ÙÀ½±Û (¿Â¶óÀÎ) »çȸºÒ¾ÈÀå¾Ö : 2022-12-17
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20694 ´ëÀü Á¦8ȸ ³»ºÐºñ ÃÊÀ½ÆÄ ¹× ±â´É°Ë»ç ¿¬¼ö°­Á : 2024-06-29 0 29 2024-05-11
20693 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 4Â÷ : 2024-06-29 0 28 2024-05-11
20692 ¼­¿ï Á¦24ȸ ´ëÇÑÀ¯Àü¼º´ë»çÁúȯÇÐȸ Á¤±âÇмú´ëȸ : 2024-06-28 0 33 2024-05-11
20691 °æ±â Á¤½Å°Ç°­ÀÇÇаú ÀÓ»ó¿¡¼­ À¯¿ëÇÑ Ä¡·á¹ý : 2024-06-26 0 40 2024-05-11
20690 ¼­¿ï (¿Â¶óÀÎ)2024 ÇѾç´ëÇб³º´¿ø È£Èí±â¾Ë·¹¸£±â ¿¬¼ö°­Á : 2024-06-22 0 30 2024-05-11
20689 ºÎ»ê °í½Å´ëÇб³º¹À½º´¿ø Á¦20ȸ °©»ó¼±¿¬¼öȸ : 2024-06-22 0 23 2024-05-11
20688 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 3Â÷ : 2024-06-22 0 8 2024-05-11
20687 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (2ÀÏÂ÷) : 2024-06-22 0 9 2024-05-11
20686 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 2 : 2024-06-21 0 18 2024-05-11
20685 ¼­¿ï ´ëÇѺÎÁ¤¸ÆÇÐȸ KHRS Annual Scientific Session 2024 (1ÀÏÂ÷) : 2024-06-21 0 12 2024-05-11
20684 ¼­¿ï Á¦50Â÷ ´ëÇѾÏÇÐȸ Çмú´ëȸ 1 : 2024-06-20 0 8 2024-05-11
20683 ¼­¿ï ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ (¿Â¶óÀÎ) ¼­¿ï°æÀÎÁöȸ 277Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-18 0 24 2024-05-11
20682 ¼­¿ï 2024 °­µ¿±¸ÀÇ»çȸ Á¦3Â÷ ¿¬¼ö±³À°(¿°Áõ¼º ÀåÁúȯ,ºñ¸¸ ¾à¹° Ä¡·á ) : 2024-06-17 0 13 2024-05-11
20681 ¼­¿ï ´ëÇÑ´ç´¢º´ÇÐȸ Á¦29Â÷ ´ç´¢º´ ¿¬¼ö°­Á : 2024-06-16 0 21 2024-05-11
20680 ¼­¿ï (¿Â¶óÀÎ) ´ëÇѼ¼Æ÷º´¸®ÇÐȸ Á¦32Â÷ º´¸®Àǻ縦 À§ÇÑ ¼¼Æ÷º´¸®±³À° 2Â÷ : 2024-06-15 0 17 2024-05-11
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷